Relation between high density lipoprotein particles concentration and cardiovascular events: a meta-analysis

Concentration of Smaller High‐Density Lipoprotein Particle (HDL‐P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA)

(2016) Daniel Seung Kim et al.   Journal of the American Heart Association

Relation of Black Race Between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (from the Dallas Heart Study)

(2015) Alvin Chandra et al.   AMERICAN JOURNAL OF CARDIOLOGY

High-Density Lipoprotein Particle Size and Concentration and Coronary Risk

(2013) Karim El Harchaoui   ANNALS OF INTERNAL MEDICINE

High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease

(2013) A. O. Akinkuolie et al.  

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

(2013) et al.   EUROPEAN HEART JOURNAL

Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

(2012) Sarah Parish et al.   CIRCULATION

High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events

(2012) Rachel H. Mackey et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

(2012) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipid and Lipoprotein Biomarkers and the Risk of Ischemic Stroke in Postmenopausal Women

(2012) Jeffrey S. Berger et al.   STROKE

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

(2011) Laurent Camont et al.   TRENDS IN MOLECULAR MEDICINE

High-density lipoproteins, platelets and the pathogenesis of atherosclerosis

(2010) Jerzy-Roch Nofer et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk

(2009) Kiran Musunuru et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipoprotein particle subclasses, cardiovascular disease and HIV infection

(2009) Daniel A. Duprez et al.   ATHEROSCLEROSIS

Lipoprotein Particle Concentrations May Explain the Absence of Coronary Protection in the Women’s Health Initiative Hormone Trials

(2008) Judith Hsia et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY